Quixidar Trademark Details

Quixidar was registered on Tuesday, September 1, 1998 and is currently owned by Sanofi-Synthelabo under the registration number 2185844 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 18 years ago on Saturday, June 4, 2005, according to the United State Patent & Trademark Office
Word Mark Quixidar
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Sanofi-Synthelabo of Paris, TX

View all trademarks for Sanofi-Synthelabo
Other Trademarks for Sanofi-Synthelabo

Previous Owners

N. V. Organon

View all trademarks for N. V. Organon
Serial Number 75329346
Registration Number 2185844
Status Date Saturday, June 4, 2005
Filing Date Saturday, June 4, 2005
Registration Date Tuesday, September 1, 1998
Attorney Pamela A. May
Domestic Representative GlaxoSmithKline

Correspondent

Pamela A. May
GlaxoSmithKline
UW2221
709 Swedeland Road
King of Prussia PA 19406

Case File Statements

Goods & Services Pharmaceutical Preparation for the Prevention and Treatment of Thrombosis

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Saturday, June 4, 2005
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.